MelissaMaversMDPhD
Pediatric Hematology & Oncology • Saint Louis, MOInstructor of Pediatrics, Division of Stem Cell Transplantation
Dr. Mavers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Pl
# Div
Saint Louis, MO 63110Phone+1 314-454-6018Fax+1 844-621-4392
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2014 - 2017
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2011 - 2014
Saint Louis University School of MedicineClass of 2011
Certifications & Licensure
MO State Medical License 2022 - 2026
CA State Medical License 2013 - 2023- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 5 citationsIdentification of unstable regulatory and autoreactive effector T cells that are expanded in patients withmutations.Šimon Borna, Esmond Lee, Jason Nideffer, Akshaya Ramachandran, Bing Wang
Science Translational Medicine. 2023-12-20 - 1 citationsInhibiting post-translational methylation to prevent GVHD.Melissa Mavers
Molecular Therapy. 2023-11-01 - 13 citationsInvariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects.Kristina Maas-Bauer, Juliane K. Lohmeyer, Toshihito Hirai, Teresa L. Ramos, Furqan M. Fazal
Blood. 2021-09-09
Press Mentions
Childhood Cancer Research Grant Given in Honor of N.J. ChildMay 25th, 2018
Three Researchers Receive Awards to Study Pediatric CancerSeptember 9th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
